RarePlex CTC Panel Kits for enumeration
CTC Panel Kits enable immunofluorescent detection of circulating tumor cells (CTCs) for enumeration and are designed for the RareCyte blood-to-result circulating tumor cell analysis platform. Enumeration Panel Kits identify EpCAM positive or negative epithelial circulating tumor cells, contain a nuclear dye and a panel of antibodies and reagents for detection of CD45 (to exclude WBC), Cytokeratin, and EpCAM in a 3-channel format.
All RarePlex CTC Panel Kits are extensively validated and held to high standards for sensitivity, specificity, and precision. Kits are available for Leica® BOND RX or Ventana® DISCOVERY® ULTRA automated staining systems. Panel Kits are ideal for use in large, multi-center circulating tumor cell enumeration trials.
RareCyte’s deployable platform for circulating tumor cell analysis:
- A clinical research laboratory can perform the entire process in their own lab
- Platform produces accurate and highly reproducible results
- Convenient pause points in workflow enable shipping between sites
- Flexibility in sample processing – A site can process AccuCyte slides and/or perform staining and analysis
- Leverage worldwide network of contract research organizations
With a 3-channel Panel Kit for enumeration, you have the flexibility to create custom assays by adding up to two biomarkers with Developer Kits.
|RarePlex® Panel and Developer Assays for CTC enumeration and characterization|
|Presented by Arturo Ramirez, Ph.D., Director of Oncology R&D
This 7 minute overview of RarePlex Panel Kits and Developer technology highlights available circulating tumor cell assays from RareCyte and presents an introduction to our assay design and validation.